• Profile

Major GI bleeding in older persons using aspirin: Incidence and risk factors in the ASPREE randomised controlled trial

Gut Mar 15, 2021

Mahady SE, Margolis KL, Chan A, et al. - As robust data on significant gastrointestinal bleeding in older people using aspirin is lacking, researchers here used data from a large randomized, controlled trial to determine the incidence, risk factors and absolute risk. An aspirin vs placebo primary prevention trial (‘ASPirin in Reducing Events in the Elderly (ASPREE)’, n = 19,114), which was carried out in community-dwelling persons aged ≥ 70 years throughout 2010–2017, was assessed for obtaining data. Overall GI bleeding risk increases by 60% in correlation with using aspirin; however, the 5-year absolute risk of serious bleeding is modest in younger, well individuals. In multivariable analyses, they identified increased bleeding risk to be correlated with age, smoking, hypertension, chronic kidney disease and obesity. These data seem to have implications for assisting patients and their clinicians to make informed decisions about prophylactic use of aspirin.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen